NFKB1 and cardiac hypertrophy: RasGAPSH3 domain‐binding proteins (G3BPs) were shown to promote isoproterenol‐induced cardiac hypertrophy via the activation of NF‐κB signalling pathway.31 Recently, auranofin, a 19S proteasome‐associated deubiquitinase inhibitor, was shown to attenuate cardiac hypertrophy by blocking NF‐κB activation.32